Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

CBPO / China Biologic Products, Inc. - Stock Institutional Ownership and Shareholders -

China Biologic Products, Inc. (NASDAQ:CBPO) has 14 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8,835,627 shares. Largest shareholders include Pw Medtech Group Ltd, Baillie Gifford & Co, Schroder Investment Management Group, Cornerstone Capital Management Holdings Llc., Norges Bank, Jupiter Asset Management Ltd, Standard Life Investments LTD, Matthews International Capital Management Llc, Greenwoods Asset Management Ltd, and Public Employees Retirement System Of Ohio. (8-0)

BRIEF-China Biologic agrees to acquire Tianxinfu from PWM

2017-10-12 reuters
* China Biologic Products Holdings Inc - ‍It has agreed to acquire 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd​ (8-1)

Hong Kong directors’ first time buys seen as a sign of undervalued stock

2016-10-30 scmp
The buying plunged while the selling among directors was low for the first time in the past four weeks based on filings on the Hong Kong exchange in the fourth week of October.